mPATH Health

About mPATH Health

mPATH is the only cancer screening navigation platform proven to close care gaps only a patient can close. In JAMA, we showed 1,300-plus patients a 44% relative increase in lung screening completion, 7.5% points absolute increase. In Annals of Internal Medicine, we showed completion doubled, over half of participants self-ordered. We navigate patients from identification through completed screening, without adding staff. The platform verifies eligibility, educates patients in plain language, motivates action with behavioral science, removes barriers to scheduling, and supports patient self-ordering: all via SMS. Live in 2–3 days from contract to live patients. No EHR integration project required. Health systems, FQHCs, academic medical centers, and Medicare Advantage plans use mPATH to close cancer screening gaps at scale. We do what patient navigators do, at 100x the scale, with published proof. 15 peer-reviewed publications. $8.5M in NIH funding. 100,000+ patients served. Performance guaranteed based on metrics that matter to your organization 10:1 ROI guaranteed for health systems, improving star ratings, and cost savings for payors as published Medicare data shows late-stage cancer costs a plan up to 7x more than early-stage diagnosis.